ADVISORY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- What: Synageva BioPharma Corp., a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need, will visit the NASDAQ MarketSite in New York City’s Times Square.
